ITFI20030328A1 - Uso della relaxina come adiuvante nella differenziazione - Google Patents

Uso della relaxina come adiuvante nella differenziazione

Info

Publication number
ITFI20030328A1
ITFI20030328A1 IT000328A ITFI20030328A ITFI20030328A1 IT FI20030328 A1 ITFI20030328 A1 IT FI20030328A1 IT 000328 A IT000328 A IT 000328A IT FI20030328 A ITFI20030328 A IT FI20030328A IT FI20030328 A1 ITFI20030328 A1 IT FI20030328A1
Authority
IT
Italy
Prior art keywords
adiuvant
relaxin
differentiation
Prior art date
Application number
IT000328A
Other languages
English (en)
Inventor
Bernardo Bigazzi
Mario Bigazzi
Original Assignee
Mario Bigazzi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mario Bigazzi filed Critical Mario Bigazzi
Priority to IT000328A priority Critical patent/ITFI20030328A1/it
Priority to US10/873,973 priority patent/US20050143299A1/en
Priority to CA002549863A priority patent/CA2549863A1/en
Priority to PCT/IT2004/000703 priority patent/WO2005060991A1/en
Priority to EP04806868A priority patent/EP1696948A1/en
Publication of ITFI20030328A1 publication Critical patent/ITFI20030328A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2221—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT000328A 2003-12-24 2003-12-24 Uso della relaxina come adiuvante nella differenziazione ITFI20030328A1 (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT000328A ITFI20030328A1 (it) 2003-12-24 2003-12-24 Uso della relaxina come adiuvante nella differenziazione
US10/873,973 US20050143299A1 (en) 2003-12-24 2004-06-22 Use of relaxin as adjuvant in the differentiation of stem cells for the reconstruction of tissues
CA002549863A CA2549863A1 (en) 2003-12-24 2004-12-17 Use of relaxin as adjuvant in the differentiation of stem cells for the reconstruction of tissues
PCT/IT2004/000703 WO2005060991A1 (en) 2003-12-24 2004-12-17 Use of relaxin as adjuvant in the differentiation of stem cells for the reconstruction of tissues
EP04806868A EP1696948A1 (en) 2003-12-24 2004-12-17 Use of relaxin as adjuvant in the differentiation of stem cells for the reconstruction of tissues

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000328A ITFI20030328A1 (it) 2003-12-24 2003-12-24 Uso della relaxina come adiuvante nella differenziazione

Publications (1)

Publication Number Publication Date
ITFI20030328A1 true ITFI20030328A1 (it) 2005-06-25

Family

ID=34685607

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000328A ITFI20030328A1 (it) 2003-12-24 2003-12-24 Uso della relaxina come adiuvante nella differenziazione

Country Status (5)

Country Link
US (1) US20050143299A1 (it)
EP (1) EP1696948A1 (it)
CA (1) CA2549863A1 (it)
IT (1) ITFI20030328A1 (it)
WO (1) WO2005060991A1 (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7878978B2 (en) 2004-03-18 2011-02-01 University Of Pittsburgh- Of The Commonwealth System Of Higher Education Use of relaxin to increase arterial compliance
CA2563433C (en) * 2004-04-30 2010-07-13 Bas Medical, Inc. Methods and compositions for control of fetal growth via modulation of relaxin
US20060052304A1 (en) * 2004-09-02 2006-03-09 Bas Medical, Inc. Method for remodeling bone and related sutures
US8496446B2 (en) * 2005-08-29 2013-07-30 Carrier Corporation Compressor muffler
EP4056196A1 (en) * 2016-10-07 2022-09-14 Beth Israel Deaconess Medical Center, Inc. Compositions comprising relaxin and methods of use thereof
WO2024047130A1 (en) 2022-08-31 2024-03-07 Relaxera Pharmazeutische Gesellschaft mbH & Co. KG Immunosuppressive medicament and method of treatment

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH661662A5 (en) * 1984-04-16 1987-08-14 Georg L Prof Dr Floersheim Product for the treatment of the skin and of the connective tissue
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5166191A (en) * 1991-08-19 1992-11-24 Genentech, Inc. Use of relaxin in cardiovascular therapy
US5766948A (en) * 1993-01-06 1998-06-16 The Regents Of The University Of California Method for production of neuroblasts
US6251863B1 (en) * 1998-09-08 2001-06-26 Samuel K. Yue Method of preventing and treating symptoms of aging and neurodegenerative dysfunctions with relaxin
AU2001236886A1 (en) * 2000-02-09 2001-08-20 Connetics Corporation Use of relaxin to treat diseases related to vasoconstriction
WO2001076592A1 (en) * 2000-04-06 2001-10-18 Acorda Therapeutics, Inc. Compositions and methods for promoting neural regeneration

Also Published As

Publication number Publication date
WO2005060991A1 (en) 2005-07-07
US20050143299A1 (en) 2005-06-30
EP1696948A1 (en) 2006-09-06
CA2549863A1 (en) 2005-07-07

Similar Documents

Publication Publication Date Title
IS8362A (is) Hámörkuð tjáning HPV 45 L1 í gersveppi
BRPI0407773B1 (pt) preparaÇço e uso de composiÇço catalisadora
MX2008006598A (es) Composiciones de edulcorante de alta potencia con vitamina y composiciones edulcoradas con la misma
CR8037A (es) Derivados de 2- acilamino- 4- feniletiazol, su preparacion y su aplicacion en terapeutica
ATE450528T1 (de) Chinazolinderivate als antitumormittel
DE602004015724D1 (de) Diazepinoindolderivate als kinaseinhibitoren
ITMI20031127A0 (it) Anticorpi anti-hgf e loro uso
FR2870125B1 (fr) Formulation du type spot-on utile en cosmetologie et en dermatologie
FI20031190A0 (fi) Antioksidantti ja sen käyttö
DE502004002225D1 (de) Selbstemulgierende Zubereitungen
ATE432077T1 (de) 5-arylpyrimidine als anti-krebs-mittel
ITFI20030328A1 (it) Uso della relaxina come adiuvante nella differenziazione
DE602004013559D1 (de) G-lactamderivate als prostaglandinagonisten
ITMI20030209A1 (it) Compressore alternativo avente struttura riducente le
ITMI20031994A1 (it) Procedimento per la preparazione di fludarabina fosfato
BR0309838B1 (pt) composiÇÕes microerbicidas e mÉtodos de preparaÇço e uso das mesmas
ITMI20031201A0 (it) Epitopi della proteina pp65 di citomegalovirus
DE112004001454D2 (de) Kolbenbolzenlager
ITRM20060440A1 (it) Uso della nifedipina per il trattamento antirughe
DE502004001936D1 (de) Herstellung von Saccharidestern
ITMI20040218A1 (it) Uso di neridronato sodico per promuovere la neoformazione ossea
ITMI20020640A1 (it) Polimero della classe delle poli-beta-carbossiacrilammidi suo uso e procedimento per prepararlo
ITFI20030317A1 (it) Adozione della caratteristica di auto-portanza nei
ITMI20040674A1 (it) Procedimento per il monitoraggio della integrita' nella determinazione di posizioni
ITMI20021205A0 (it) Uso di proteine per il trattamento della leishmaniosi